BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19035118)

  • 1. [Proteomics study of papillary thyroid carcinoma].
    Shi J; Lu ZH; Cui QC
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):465-70. PubMed ID: 19035118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.
    Brown LM; Helmke SM; Hunsucker SW; Netea-Maier RT; Chiang SA; Heinz DE; Shroyer KR; Duncan MW; Haugen BR
    Mol Carcinog; 2006 Aug; 45(8):613-26. PubMed ID: 16788983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDLIM5 identified by label-free quantitative proteomics as a potential novel biomarker of papillary thyroid carcinoma.
    Wei X; Zhang Y; Yu S; Li S; Jiang W; Zhu Y; Xu Y; Yang C; Tian G; Mi J; Bergquist J; Zhao M; Song F
    Biochem Biophys Res Commun; 2018 May; 499(2):338-344. PubMed ID: 29574154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic profiling of follicular and papillary thyroid tumors.
    Sofiadis A; Becker S; Hellman U; Hultin-Rosenberg L; Dinets A; Hulchiy M; Zedenius J; Wallin G; Foukakis T; Höög A; Auer G; Lehtiö J; Larsson C
    Eur J Endocrinol; 2012 Apr; 166(4):657-67. PubMed ID: 22275472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features.
    Gianì F; Vella V; Nicolosi ML; Fierabracci A; Lotta S; Malaguarnera R; Belfiore A; Vigneri R; Frasca F
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1168-78. PubMed ID: 26151334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.
    Zhu X; Sun T; Lu H; Zhou X; Lu Y; Cai X; Zhu X
    J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics for the diagnosis of thyroid lesions: preliminary report.
    Pagni F; Mainini V; Garancini M; Bono F; Vanzati A; Giardini V; Scardilli M; Goffredo P; Smith AJ; Galli M; De Sio G; Magni F
    Cytopathology; 2015 Oct; 26(5):318-24. PubMed ID: 25040579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
    Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis.
    Ma H; Yan J; Zhang C; Qin S; Qin L; Liu L; Wang X; Li N
    Int J Clin Exp Pathol; 2014; 7(11):7999-8007. PubMed ID: 25550843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis.
    Ferraro A; Schepis F; Leone V; Federico A; Borbone E; Pallante P; Berlingieri MT; Chiappetta G; Monaco M; Palmieri D; Chiariotti L; Santoro M; Fusco A
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2834-43. PubMed ID: 23666966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancers.
    Burniat A; Jin L; Detours V; Driessens N; Goffard JC; Santoro M; Rothstein J; Dumont JE; Miot F; Corvilain B
    Endocrinology; 2008 Oct; 149(10):5107-17. PubMed ID: 18583418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential proteomic and phenotypic behaviour of papillary and anaplastic thyroid cell lines.
    Musso R; Di Cara G; Albanese NN; Marabeti MR; Cancemi P; Martini D; Orsini E; Giordano C; Pucci-Minafra I
    J Proteomics; 2013 Sep; 90():115-25. PubMed ID: 23385357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global profiling of the signaling network of papillary thyroid carcinoma.
    Huang K; Cui M; Ye F; Li Y; Zhang D
    Life Sci; 2016 Feb; 147():9-14. PubMed ID: 26776835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.
    Prasad ML; Huang Y; Pellegata NS; de la Chapelle A; Kloos RT
    Histopathology; 2004 Jul; 45(1):39-46. PubMed ID: 15228442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor expression is linked to potential markers of human thyroid papillary carcinoma.
    Izkhakov E; Somjen D; Sharon O; Knoll E; Aizic A; Fliss DM; Limor R; Stern N
    J Steroid Biochem Mol Biol; 2016 May; 159():26-30. PubMed ID: 26907966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
    Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma.
    Sofiadis A; Dinets A; Orre LM; Branca RM; Juhlin CC; Foukakis T; Wallin G; Höög A; Hulchiy M; Zedenius J; Larsson C; Lehtiö J
    Thyroid; 2010 Oct; 20(10):1067-76. PubMed ID: 20629554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.